Clinical Trials Directory

Trials / Completed

CompletedNCT02157155

A Study of Intracellular Signaling in Muscle and Fat Cells During Ketosis

The Role of ATGL and G0/G1 Switch Gene Complex in Lipopolysaccaride (LPS) Induced Ketosis - a Controlled, Randomised, Clinical Experimental Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Hypothesis 1. To define whether stimulation of ATGL and suppression of G0/G1 switch gene occur in the initial phases of diabetic ketoacidosis and thus can be identified as the primary mechanisms behind this life threatening condition. 2. Make a human model for studying ketoacidosis. The investigators plan to reduce in their regular insulin over night. In the morning we administer endotoxin, which together with a relative lack of insulin will initiate ketogenesis - a state of ketoacidosis. On another occasion strict glycemic control is imposed by means of intravenous insulin. The testing is done two separate days with at least 3 weeks in between and patients are admitted to hospital the evening before the day of testing. The investigators use isotopic tracers to determine metabolic fluxes and analyse fat (ATGL, G0/G1 switch gene) and muscle biopsies.

Conditions

Interventions

TypeNameDescription
BIOLOGICALLPSLPS is endotoxin from gram negative bacteria. It is used scientifically to mimic infection lasting 4-8 hours.

Timeline

Start date
2014-06-01
Primary completion
2015-03-01
Completion
2015-09-01
First posted
2014-06-05
Last updated
2015-12-02

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02157155. Inclusion in this directory is not an endorsement.